Abandoned cancer drug resurrected by San Diego startup

Favicon UT San Diego

An experimental blood cancer drug shelved for safety concerns is being brought back to clinical development. San Diego startup Impact Biomedicines said Friday it has raised $22.5 million from the venture capital firm Medixci to help get the drug to market. Called fedratinib, the drug treats the...

Read the full article here: UT San Diego


The post: «Abandoned cancer drug resurrected by San Diego startup» has been published on the website UT San Diego where, everyday, you can find the latest news about San Diego's area.



Get more articles about this topic

Leave a comment